Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
Resource Type
Article
Authors
Deville, Jaime G ; Carter, Michele F ; Mansky, Hannah ; Pinto, Jorge A ; Ferreira, Flavia F ; Romeiro, Juliana ; D'Angelo, Jessica ; Williams, Ruth ; Jundi, Fernanda ; Cruz, Maria Letícia Santos ; Sidi, Claude Leon ; Kataike, Hajira ; Owor, Maxensia ; Ahimbisibwe, Grace Miriam ; van Rensburg, Ms Anita Janse ; Andrea, Catherine V ; Ponatshego, Ponego L ; Budu, Marian ; Tirelo, Lesedi ; Masheto, Gaerolwe R ; Raesi, Mpho S. ; Ramogodiri, Moakanyi ; Chanthong, Jiraporn ; Khamrong, Chintana ; Aurpibul, Linda ; Fairlie, Lee ; Patel, Faeezah ; Soma-Kashiram, Hamisha ; Archary, Moherndran ; Hanley, Sherika ; Govender, Vani ; Sturzbecher, Fernanda Tomé ; Cervi, Maria Célia ; Mmbaga, Blandina T ; Njau, Boniface ; Matibe, Petronilla ; Mukonowenzou, Ruvimbo ; Marozva, Catherine C ; Keter, Winnie C ; Bii, Priscilla C ; Ounchanum, Pradthana ; Cressey, Tim R ; Sukrakanchana, Pra-ornsuda ; Chokephaibulkit, Kulkanya ; Rungmaitree, Supattra ; Pilotto, Jose Henrique ; Fernandes, Luis Eduardo ; Gomes, Ivete Martins ; Ruel, Theodore D ; Acosta, Edward P ; Liu, Jessica P ; Gray, Kathryn P ; George, Kathleen ; Montañez, Nicole ; Popson, Stephanie ; Buchanan, Ann M ; Bartlett, Mattie ; Dayton, Dale ; Anthony, Patricia ; Brothers, Cynthia ; Vavro, Cynthia ; Singh, Rajendra ; Koech, Lucy ; Vhembo, Tichaona ; Dobbels, Els F M ; Hazra, Rohan ; Townley, Ellen ; Wiznia, Andrew
Source
In The Lancet HIV May 2022 9(5):e332-e340
Subject
Primary Research Articles
Language
ISSN
2352-3018